Can pharmacokinetic/pharmacodynamic targets be achieved with voriconazole in the treatment of urinary tract infections caused by Candida spp. with reduced susceptibility to fluconazole? (academic.oup.com)

Authors: Boglione-Kerrien C … Guegan H Journal: Journal of Antimicrobial Chemotherapy Published: 2026-07-02 DOI: https://doi.org/10.1093/jac/dkag231